Disease-Vaccine-Landing-Page

In May 2021, Israeli health officials reported a possible link between the Pfizer COVID-19 vaccine and myocarditis after reporting that 62 cases had been reported following vaccination. Of these cases,...

The National Institute of Allergy and Infectious Diseases (NIAID) headed by Dr. Anthony Fauci issued a press release on March 16, 2020 announcing that a Phase 1 human clinical trial...

Individuals who experience an allergic reaction after a dose of Novavax COVID-19 vaccine should not receive another dose. Additionally, persons who are allergic to any component of the Novavax COVID-19...

High doses of vitamin C given intravenously (IV) have been used to treat COVID-19. Three clinical trials and several smaller studies reported successful outcomes among patients who received IV vitamin...

In early August 2020, Mayo Clinic researchers reported that blood plasma donated from individuals who had recovered from COVID-19, was helpful despite a lack a formal data to support its...

Because the SARS-CoV-2 virus was new, there were no FDA approved drugs specific to this new virus. This resulted in some health care professionals using their clinical experience to treat...

Emergency Use Authorization (EUA) is a status given to experimental and licensed products by the FDA during a public health emergency, as defined under federal law. Monoclonal AntibodiesIn 2020, the...

According to the CDC, most people who become ill with COVID-19 will not require any specific treatment, with over-the-counter fever and pain reducers to relieve aches and pains associated with...

A review published in May 2020 stated that while there were no published nutrition studies specific to COVID-19 and SARS-CoV-2, there was evidence from acute respiratory distress syndrome in other...

Individuals who are deficient in vitamin D have been found to be at an increased risk of severe COVID-19 disease. In addition to strengthening teeth and bones, vitamin D...